4,6-PYRIMIDINE DICARBOXYLIC ACID

4,6-Pyrimidinedicarboxylic acid (CAS 16490-02-1) is manufactured directly by Hunan HuaTeng Pharmaceutical Co., Ltd. to pharmaceutical grade under the supplier's in-house standard. It is used in the preparation of inhibitor scaffolds targeting the human JMJD2 subfamily of histone demethylases and serves as an intermediate for the COVID-19 candidate drug brilacidin. It is sold into North America, Central/South America, Western Europe, and Asia.